Helicobacter pylori and Cancer – National Cancer Institute, In 1994, the International Agency for Research on Cancer classified H. pylori as a carcinogen, or cancer-causing agent, in humans, despite conflicting results at the time. Since then, it has been increasingly accepted that colonization of the stomach with H. pylori is an important cause of gastric cancer and of gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
10/1/2008 · H. pylori increases risk for one major form of cancer (NCGC) and yet appears to protect against a less common but rapidly increasing malignancy (EAC), and inversely correlates with (and so may protect against) other important diseases (e.g.
allergic asthma, rhinitis, and atopy) that have been increasing (especially in children) as H. pylori has been disappearing .
Helicobacter pylori infection may confer protection against oesophageal adenocarcinoma, according to the results of a study from Stanford University School of Medicine, CA, USA. Catherine de Martel and Augusto Llosa analysed records from around 130 000 patients who had been followed since the 1960s. 52 of this group had developed oesophageal adenocarcinoma.
However, the observation that H. pylori?positive subjects with an antral?predominant, non?atrophic gastritis have an increased risk of oesophageal adenocarcinoma and that H pylori atrophic gastritis is associated with an increased risk of oesophageal squamous cell carcinoma indicate that H pylori is not always protective with respect to serious oesophageal disease.
7/1/2010 · The findings add to a growing body of evidence suggesting that H. pylori might somehow be protective against esophageal cancers, even as it increases the risk of gastric cancer. Dr. Whiteman, head of the Cancer Control Laboratory at the Queensland (Australia) Institute of Medical Research looked at 794 Australian patients aged 18-79 years with a primary invasive cancer of the esophagus or.
HpaA had been proposed to be a promising vaccine candidate against H. pylori infection. However, the effect of non-lipidated recombinant HpaA (rHpaA) to stimulate immune response was not very ideal, and the protective effect against H. pylori infection was also limited. Here, we hypothesized that low immunogenicity of rHpaA may attribute to lacking the immunostimulatory properties endowed by the.
In a meta-analysis published in the World Journal of Gastroenterology the authors concluded that H. pylori infection is a strong protective factor against oesophageal adenocarcinoma. The underlying mechanism by which H. pylori protects the oesophagus is yet.
10/17/2006 · One theory is that H. pylori infection helps protect against junctional cancer by reducing the esophagus’ exposure to stomach acid, Kamangar says. Acid reflux Acid reflux involves the backup of…
Chronic infection with the gastric bacterial pathogen Helicobacter pylori causes gastritis and predisposes carriers to a high risk of developing gastric and duodenal ulcers, gastric cancer, and gastric lymphoma, but has also recently been shown to protect against certain allergic and chronic inflammatory disorders. The immunomodulatory properties that allow the bacteria to persist for decades in infected individuals.
H. pylori DNA decreases proinflammatory cytokine production by dendritic cells and attenuates dextran sodium sulfate-induced coli-tis in mice. We showed that H. pylori DNA, which has been found in the colon and stool of infected patients [15,16], has immunoregula-tory properties [17]. H. pylori DNA suppresses type 1 interferon and
